Which statement about immunogenicity is true?

• A. Higher immunogenicity typically leads to stronger immune responses and memory formation
• B. Higher immunogenicity always causes worse disease
• C. Immunogenicity determines the maximum lifespan of the host
• D. Immunogenicity is unrelated to vaccine effectiveness

Answer: (A)

Immunogenicity is the ability of an antigen or pathogen to provoke an immune response. When something is highly immunogenic, it more effectively activates the immune system, leading to stronger B cell (antibody) and T cell responses and, importantly, formation of memory cells. That memory is what underlies long-term protection, so higher immunogenicity generally results in a more robust and durable immune defense after vaccination or infection.

In vaccines, boosting immunogenicity is a primary goal because it increases the likelihood that the body will produce neutralizing antibodies and memory lymphocytes that respond rapidly if the real pathogen is encountered again. This is why adjuvants or conjugation strategies are used—to enhance immunogenicity when the antigen by itself might not be sufficiently stimulating.

The other statements don’t fit the concept. Immunogenicity does not dictate disease severity or lifespan; a highly immunogenic response can be protective rather than harmful and life span is influenced by many factors beyond immune activation. And immunogenicity is not unrelated to vaccine effectiveness; it is a key determinant of how well a vaccine can induce protective immunity.